4
Changes in Ownership
BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001144204-10-023640
Director sold 200,000 shares at an average $0.29 ($58,290)
From the SEC's structured data for this filing
Trades in this filing
SHORR ROBERT G L · Director
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2009-10-16 | Sale : show line 1 in the form | −5,000 | $0.28 | $1,400 | 295,000 | D |
| 2009-10-19 | Sale : show line 2 in the form | −50,000 | $0.27 | $13,500 | 245,000 | D |
| 2009-10-20 | Sale : show line 3 in the form | −50,000 | $0.28 | $14,000 | 195,000 | D |
| 2009-10-21 | Sale : show line 4 in the form | −25,000 | $0.29 | $7,250 | 170,000 | D |
| 2009-10-22 | Sale : show line 5 in the form | −10,000 | $0.37 | $3,700 | 140,000 | D |
| 2009-10-22 | Sale : show line 6 in the form | −20,000 | $0.30 | $6,000 | 140,000 | D |
| 2009-10-26 | Sale : show line 7 in the form | −40,000 | $0.31 | $12,440 | 100,000 | D |
| Open-market sales · 200,000 sh · avg $0.29 · $58,290 | ||||||
Loading xslF345X03/v182969_ex.xml…